Orpyx key facts
- Developer of wearable sensor-based healthcare tools designed to prevent devastating complications to feet from peripheral neuropathy.
- It has raised $38.5M; the latest was Later Stage VC ($20.0M) in Sep 2024.
- Notable investors include Creative Destruction Lab, Perceptive Advisors, Next Ventures (Texas), Anges Québec, Aphelion Capital — 19 tracked in total.
- Status: Privately Held (backing).
Who backs Orpyx
19+- ·The complete investor list: 19 names
- ·Watch Orpyx: the Monday email on marks, rounds and moves
Orpyx funding rounds
No funding rounds for Orpyx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Orpyx investors
19 investors are on record for Orpyx, including Creative Destruction Lab, Perceptive Advisors, Next Ventures (Texas) and Anges Québec.
About Orpyx
Developer of wearable sensor-based healthcare tools designed to prevent devastating complications to feet from peripheral neuropathy. The company's tools understand the daily pressure on the feet to avoid irreversible damage and manage peripheral neuropathy, enabling people to take control of their health, prevent debilitating complications, and extend their health span.
- Sector
- Healthcare
- HQ
- Calgary, Canada
- Founded
- 2010
- Employees
- 68
- Website
- orpyx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Orpyx doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.